Cell Insight (Aug 2022)

Phosphorylated STYK1 restrains the inhibitory role of EGFR in autophagy initiation and EGFR-TKIs sensitivity

  • Cefan Zhou,
  • Xueying Dong,
  • Ming Wang,
  • Xuehong Qian,
  • Miao Hu,
  • Kai Liang,
  • Yanyan Liang,
  • Rui Zhang,
  • Yuan Huang,
  • Hao Lyu,
  • Shuai Xiao,
  • Yongfei Tang,
  • Declan William Ali,
  • Marek Michalak,
  • Xing-Zhen Chen,
  • Jingfeng Tang

Journal volume & issue
Vol. 1, no. 4
p. 100045

Abstract

Read online

Epidermal growth factor receptor (EGFR) plays critical roles in cell proliferation and tumorigenesis. Autophagy has emerged as a potential mechanism involved in the acquired resistance to anti-EGFR treatments, however, the molecular mechanisms has not been fully addressed. In this study, we identified EGFR interacts with STYK1, a positive autophagy regulator, in EGFR kinase activity dependent manner. We found that EGFR phosphorylates STYK1 at Y356 site and STYK1 inhibits activated EGFR mediated Beclin1 tyrosine phosphorylation and interaction between Bcl2 and Beclin1, thus enhances PtdIns3K-C1 complex assembly and autophagy initiation. We also demonstrated that STYK1 depletion increased the sensitivity of NSCLC cells to EGFR-TKIs in vitro and in vivo. Moreover, EGFR-TKIs induced activation of AMPK phosphorylates STYK1 at S304 site. STYK1 S304 collaborated with Y356 phosphorylation to enhance the EGFR-STYK1 interaction and reverse the inhibitory effects of EGFR to autophagy flux. Collectively, these data revealed new roles and cross-talk between STYK1 and EGFR in autophagy regulation and EGFR-TKIs sensitivity in NSCLC.

Keywords